Ramaswamy's Roivant Inks $650M R&D Deal With This Tiny Diabetes Biotech
With the deal in hand, Roivant has stepped into the world of metabolic diseases. Source: BioSpace
With the deal in hand, Roivant has stepped into the world of metabolic diseases. Source: BioSpace
The fast-growing company will anchor 399 Binney St., an Alexandria Real Estate Equities property. Source: BioSpace
It took more than 8 months and a series of sweetened offers, but Sanofi was able to close their $11.6B deal to buy Bioverativ without triggering an auction. Source: BioSpace
The first of the pink slips at Sandoz' generic-drug manufacturing facility in Broomfield, Colo. have been handed out. Source: BioSpace
Syndesi will work to modulate the synaptic vesicle protein SV2A. Source: BioSpace
Nebula Genomic plans to offer inexpensive genetic testing, but allow the consumer to own their own genetic data. Source: BioSpace
ImmunoPrecise announces the appointment of Dr. Jennifer Bath, as the new President and CEO of the Company effective February 21, 2018. Source: BioSpace
Shares of Pieris have climbed more than 10 percent this morning after the company announced it inked a multi-program immuno-oncology collaboration with Seattle Genetics. Source: BioSpace
Less than two months into the year, Teva's new chief has already effectively written off a recovery for 2018. Source: BioSpace
Elastagen's revolutionary technology is based on recombinant human tropoelastin, the precursor of elastin which is a key component of youthful skin. Source: BioSpace